Skip to main content
PROVEXIS PLC logo

PROVEXIS PLC — Investor Relations & Filings

Ticker · PXS ISIN · GB00B0923P27 LEI · 21380042E3Y3N9VZ6N48 IL Professional, scientific and technical activities
Open in API
Filings indexed 207 across all filing types
Latest filing 2021-12-31 Earnings Release
Country GB United Kingdom
Listing IL PXS

About PROVEXIS PLC

https://www.provexis.org/

Provexis PLC is a life sciences company that develops, licenses, and commercializes functional ingredients for the global food, beverage, and dietary supplement markets. The company's principal technology is Fruitflow®, a patented, scientifically-proven bioactive ingredient derived from tomatoes. Fruitflow® is designed to support cardiovascular health by helping to maintain normal blood platelet aggregation, which contributes to healthy blood flow. Provexis licenses its technology to business partners for inclusion in their consumer products.

Recent filings

Filing Released Lang Actions
Half-year Report
Earnings Release Classification · 100% confidence The document explicitly states it contains 'UNAUDITED INTERIM RESULTS FOR SIX MONTHS TO 30 SEPTEMBER 2021'. This clearly indicates a comprehensive financial report covering a period shorter than a full year (six months). This aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it is a detailed report (length > 48k chars), it is the report itself, not just an announcement of its publication (RPA). H1 2021
2021-12-31 English
Second Price Monitoring Extn
Regulatory Filings Classification · 99% confidence The document begins with 'RNS Number' and is dated, indicating a regulatory announcement. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific operational notice related to trading halts or volatility controls on a stock exchange. This type of general, time-sensitive regulatory notification that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified under the general regulatory announcement category, RNS (Regulatory News Service). The document length is short (1930 chars), and it is a direct announcement, not a link to a larger report.
2021-11-26 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1913 characters) and contains the header 'RNS Number : 7837T'. It announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange and explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, which is approved as a Primary Information Provider. This structure—a brief, specific operational announcement disseminated via the RNS system—fits best under the general 'Regulatory Filings' category, as it is not a core financial report (like 10-K, IR, ER) nor a specific announcement like a dividend (DIV) or director dealing (DIRS). It is a miscellaneous regulatory update.
2021-11-26 English
Result of AGM
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document explicitly states 'Result of AGM' and provides a detailed table showing the 'Votes for', 'Votes against', and 'Votes withheld' for several numbered resolutions presented at the Annual General Meeting. This content directly corresponds to the reporting of voting outcomes from a general meeting. The RNS Number format and the concluding boilerplate text confirm it is a regulatory announcement, but the core content is the voting result. This matches the definition for 'Declaration of Voting Results & Voting Rights Announcements' (DVA).
2021-11-04 English
By-Health Fruitflow agreement and support in R&D
M&A Activity Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 3712R) on November 4, 2021. It details a significant business event: the entry into a long-term strategic co-operation framework agreement between Provexis plc and By-Health Co., Ltd. for the supply and distribution of the Fruitflow ingredient. This announcement discusses a major commercial transaction, exclusive rights, regulatory progress (SAMR in China), and future supply chain planning. Since it is a formal announcement of a significant business development that is not a periodic financial report (like 10-K or IR), a dividend notice, or a management change, it fits best under the general category for regulatory announcements that convey material, non-financial business news. Given the context of RNS distribution and the nature of the announcement (a major commercial agreement), the most appropriate classification is Regulatory Filings (RNS), as it is a broad category for material company news disseminated via regulatory channels that doesn't fit the more specific codes like CAP (Capital/Financing Update) or TAR (M&A Activity). While it involves a supply agreement, it is primarily a disclosure of a strategic partnership, making RNS the best fit among the provided options for a general, material regulatory disclosure.
2021-11-04 English
Group of companies' accounts made up to 2021-03-31
Regulatory Filings
2021-10-08 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.